New Key Statistics Module, Z-Score and F-Score
NAS:ABVC Key Ratios
| Market Cap $ M | 6.78 |
| Enterprise Value $ M | 8.52 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.79 |
| Price/Sales | 13.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.90 |
| Beneish M-Score | -4.66 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 1.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.33 |
| EV-to-EBITDA | -1.34 |
| PEG | -- |
| Shares Outstanding M | 12.24 |
| Net Margin (%) | -1,619.65 |
| Operating Margin % | -1,244.20 |
| Pre-tax Margin (%) | -1,700.00 |
| Quick Ratio | 0.34 |
| Current Ratio | 0.34 |
| ROA % (ttm) | -55.22 |
| ROE % (ttm) | -98.30 |
| ROIC % (ttm) | -39.18 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.97 |
ABVC Number of Guru Trades
ABVC Volume of Guru Trades
Gurus Latest Trades with NAS:ABVC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABVC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ABVC BioPharma Inc Insider Transactions
No Available Data
News about NAS:ABVC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers